Xen45 Gel Stent implant: patient reported outcomes
Hassan, Faaiq Thomson, Luke Thomas Middleton Toor, Gurpal Al-Fahad, Qusay
Hassan, Faaiq
Thomson, Luke Thomas Middleton
Toor, Gurpal
Al-Fahad, Qusay
Citations
Altmetric:
Affiliation
South Warwickshire University NHS Foundation Trust
Other Contributors
Publication date
2019-09
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Our aim was to report quality of life (QOL) outcomes following Xen45 Gel Stent implantation surgery in patients suffering with primary open angle glaucoma (POAG). A retrospective analysis was performed on all patients who had Xen45 implantation surgery during a 2-year period (Jun, 2016-Apr, 2018). Of 52 consecutive patients were included with a total of 58 eyes being operated on. QOL was compared both pre-operatively and 6 weeks post-operatively using the GQL-15 questionnaire. There was an overall improvement in GQL-15 summary scores for our patient group. All item scores showed either no change or some degree of improvement. The Xen45 Gel Stent Implant is a promising new intervention which has shown improved QOL scores in our patient group. Further, higher power studies are now needed to compare the Xen45 to trabeculectomy (TE), which is currently the gold standard.
Keywords: Xen45 Gel Stent implant; glaucoma; minimally invasive glaucoma surgery.
Citation
Hassan F, Thomson LTM, Toor G, Alfahad Q. Xen45 Gel Stent implant: patient reported outcomes. Int J Ophthalmol. 2019 Sep 18;12(9):1503-1506. doi: 10.18240/ijo.2019.09.21.
Type
Article